X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
organotechnetium compounds - pharmacokinetics (1534) 1534
animals (1163) 1163
humans (1142) 1142
male (925) 925
radionuclide imaging (821) 821
tissue distribution (813) 813
radiopharmaceuticals - pharmacokinetics (795) 795
female (757) 757
mice (533) 533
rats (432) 432
radiology, nuclear medicine & medical imaging (421) 421
middle aged (407) 407
adult (362) 362
organotechnetium compounds - chemistry (341) 341
index medicus (340) 340
aged (305) 305
organotechnetium compounds - chemical synthesis (289) 289
tomography, emission-computed, single-photon (278) 278
organotechnetium compounds (237) 237
radiopharmaceuticals - chemical synthesis (213) 213
heart - diagnostic imaging (199) 199
technetium (197) 197
myocardium - metabolism (187) 187
organophosphorus compounds - pharmacokinetics (178) 178
metabolic clearance rate (177) 177
cell line, tumor (168) 168
oximes - pharmacokinetics (157) 157
tomography, emission-computed, single-photon - methods (156) 156
radiopharmaceuticals (145) 145
sensitivity and specificity (142) 142
liver - metabolism (138) 138
rabbits (136) 136
brain - metabolism (134) 134
brain - diagnostic imaging (132) 132
time factors (129) 129
rats, sprague-dawley (128) 128
reproducibility of results (127) 127
spect (126) 126
cysteine - analogs & derivatives (121) 121
rats, wistar (121) 121
radiopharmaceuticals - chemistry (119) 119
nuclear medicine (117) 117
liver - diagnostic imaging (116) 116
organotechnetium compounds - metabolism (115) 115
medicine & public health (109) 109
mice, nude (108) 108
ligands (104) 104
imaging / radiology (100) 100
technetium tc 99m exametazime (99) 99
isotope labeling (96) 96
mice, inbred balb c (96) 96
drug stability (95) 95
kidney - metabolism (91) 91
dogs (89) 89
cysteine - pharmacokinetics (87) 87
kidney - diagnostic imaging (86) 86
adolescent (85) 85
kinetics (84) 84
organ specificity (84) 84
chromatography, high pressure liquid (83) 83
oncology (83) 83
technetium tc 99m sestamibi - pharmacokinetics (83) 83
oligopeptides - pharmacokinetics (82) 82
isotope labeling - methods (80) 80
biodistribution (79) 79
aged, 80 and over (76) 76
organotechnetium compounds - administration & dosage (74) 74
in vitro techniques (73) 73
technetium - pharmacokinetics (72) 72
cardiology (71) 71
molecular structure (69) 69
technetium-99m (69) 69
tl-201 (69) 69
imino acids - pharmacokinetics (67) 67
perfusion (67) 67
tc-99m (66) 66
apoptosis (65) 65
tumor cells, cultured (65) 65
cancer (64) 64
neoplasm transplantation (63) 63
organotechnetium compounds - blood (62) 62
biological transport (59) 59
diagnosis (59) 59
reference values (58) 58
scintigraphy (58) 58
annexin a5 - pharmacokinetics (57) 57
child (57) 57
coronary disease - diagnostic imaging (57) 57
disease models, animal (55) 55
tumors (55) 55
radiopharmaka (54) 54
breast neoplasms - diagnostic imaging (53) 53
organometallic compounds - pharmacokinetics (53) 53
protein binding (52) 52
rats, inbred strains (52) 52
technetium tc 99m dimercaptosuccinic acid (52) 52
cerebrovascular circulation (51) 51
technetium - chemistry (51) 51
myocardial ischemia - diagnostic imaging (50) 50
imaging (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1816) 1816
Japanese (42) 42
Chinese (22) 22
German (19) 19
Spanish (11) 11
French (7) 7
Polish (6) 6
Russian (6) 6
Slovak (4) 4
Italian (2) 2
Croatian (1) 1
Czech (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Endocrine-Related Cancer, ISSN 1351-0088, 03/2010, Volume 17, Issue 1, pp. R53 - R73
Somatostatin receptor imaging (SRI) with [ 111 In-DTPA 0 ]octreotide has proven its role in the diagnosis and staging of gastroenteropancreatic neuroendocrine... 
LUNG-CANCER | POSITRON-EMISSION-TOMOGRAPHY | ONCOLOGY-GROUP | ISLET-CELL CARCINOMA | ONCOLOGY | PHASE-I TRIAL | RADIONUCLIDE THERAPY | ENDOCRINOLOGY & METABOLISM | LOW-GRADE | MEDULLARY-THYROID CARCINOMA | QUALITY-OF-LIFE | OCTREOTIDE SCINTIGRAPHY | Humans | Digestive System Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Yttrium Radioisotopes - pharmacokinetics | Octreotide - pharmacokinetics | Digestive System Neoplasms - drug therapy | Gallium Radioisotopes - therapeutic use | Digestive System Neoplasms - diagnostic imaging | Neuroendocrine Tumors - diagnostic imaging | Receptors, Somatostatin - analysis | Organometallic Compounds - therapeutic use | Yttrium Radioisotopes - therapeutic use | Somatostatin - analogs & derivatives | Radiopharmaceuticals - pharmacokinetics | Octreotide - analogs & derivatives | Organometallic Compounds - pharmacokinetics | Treatment Outcome | Clinical Trials as Topic | Combined Modality Therapy | Indium Radioisotopes - pharmacokinetics | Positron-Emission Tomography - methods | Octreotide - therapeutic use | Somatostatin - pharmacokinetics | Peptides, Cyclic - pharmacokinetics | Neuroendocrine Tumors - radiotherapy | Animals | Organotechnetium Compounds - pharmacokinetics | Positron-Emission Tomography - standards | Receptors, Somatostatin - drug effects | Gallium Radioisotopes - pharmacokinetics | Neuroendocrine Tumors - drug therapy | Peptides, Cyclic - therapeutic use | Quality of Life | Indium Radioisotopes - therapeutic use | Somatostatin - therapeutic use | Radiopharmaceuticals - therapeutic use
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 10/2016, Volume 57, Issue Suppl 3, pp. 79S - 89S
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 04/2006, Volume 47, Issue 4, pp. 668 - 678
Journal Article
Journal Article
Journal Article
Journal Article
The Journal of Nuclear Medicine, ISSN 0161-5505, 05/2009, Volume 50, Issue 5, pp. 781 - 789
Journal Article
Journal of Nuclear Medicine, ISSN 0161-5505, 05/2012, Volume 53, Issue 5, pp. 716 - 722
Journal Article
Journal Article
Nuclear Medicine and Biology, ISSN 0969-8051, 2008, Volume 35, Issue 4, pp. 401 - 411
Abstract Introduction Radionuclide imaging can be a useful tool for the diagnosis of prostate cancer. Bombesin (BBN) is a molecule with high affinity for... 
Radiology | Bombesin analogs | technetium 99m ( 99mTc)-HYNIC-BBN | Prostate cancer | 99mTcN(PNP6)-Cys-BBN | technetium 99m | Tc)-HYNIC-BBN | TcN(PNP6)-Cys-BBN | VISUALIZATION | VITRO/IN VIVO | RECEPTOR | TC-99M-RADIOPHARMACEUTICALS | BIODISTRIBUTION | technetium 99m (Tc-99m)-HYNIC-BBN | prostate cancer | bombesin analogs | PEPTIDES | TC-99M | RADIOPHARMACEUTICALS | (TcN)-Tc-99m(PNP6)-Cys-BBN | IN-VIVO | BOMBINA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Niacinamide - analogs & derivatives | Nitrogen Compounds - pharmacokinetics | Phosphines - pharmacokinetics | Organotechnetium Compounds - chemical synthesis | Male | Metabolic Clearance Rate | Radiopharmaceuticals - chemical synthesis | Tissue Distribution | Hydrazines - chemistry | Prostate - pathology | Phosphines - chemistry | Bombesin - analogs & derivatives | Niacinamide - chemistry | Nitrogen Compounds - chemical synthesis | Drug Design | Niacinamide - pharmacokinetics | Prostatic Neoplasms - diagnostic imaging | Bombesin - chemistry | Drug Evaluation, Preclinical | Disease Models, Animal | Pancreas - diagnostic imaging | Organotechnetium Compounds - chemistry | Radiopharmaceuticals - pharmacokinetics | Drug Stability | Hydrazines - pharmacokinetics | Cysteine - chemistry | Isotope Labeling - methods | Animals | Organotechnetium Compounds - pharmacokinetics | Prostate - diagnostic imaging | Radionuclide Imaging | Cell Line, Tumor | Hydrophobic and Hydrophilic Interactions | Cysteine - pharmacokinetics | Mice | Bombesin - pharmacokinetics | Receptors, Bombesin - analysis | Bombesin | Oncology, Experimental | Gastrin | Technetium | Diagnostic imaging | Diagnosis | Research | Isotopes | Cancer
Journal Article